140 related articles for article (PubMed ID: 9680079)
1. Endothelium-dependent vasorelaxant and anti-aggregatory effect and mechanism of action of some antifibrinogen RGD (Arg-Gly-Asp-containing) peptides.
Torday LL; Pataricza J; Balogh GE; Zarándi M; Penke B; Papp JG
J Pharm Pharmacol; 1998 Jun; 50(6):667-71. PubMed ID: 9680079
[TBL] [Abstract][Full Text] [Related]
2. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
[TBL] [Abstract][Full Text] [Related]
3. Vasomotor effects of arg-gly-asp (RGD) peptides are limited and not related to endothelium-derived hyperpolarizing factor-mediated relaxation in rat mesenteric arteries.
Bakker EN; Balt JC; Pfaffendorf M; Spaan JA; VanBavel E
Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):873-6. PubMed ID: 11703386
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic and vasorelaxant properties of a novel synthetic RGD peptide containing nitric oxide.
Gurevich VS; Lominadze DG; Adeagbo AS; Burov SV; Popov YuG ; Leko MV; Miller FN; Schuschke DA
Pharmacology; 1997 Jul; 55(1):1-9. PubMed ID: 9309795
[TBL] [Abstract][Full Text] [Related]
5. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
[TBL] [Abstract][Full Text] [Related]
6. Vasorelaxant effects of Cerebralcare Granule® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
[TBL] [Abstract][Full Text] [Related]
7. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
8. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
Zembowicz A; Hatchett RJ; Jakubowski AM; Gryglewski RJ
Br J Pharmacol; 1993 Sep; 110(1):151-8. PubMed ID: 7693274
[TBL] [Abstract][Full Text] [Related]
9. The Curcumin-Induced Vasorelaxation in Rat Superior Mesenteric Arteries.
Zhang H; Liu H; Chen Y; Zhang Y
Ann Vasc Surg; 2018 Apr; 48():233-240. PubMed ID: 28943490
[TBL] [Abstract][Full Text] [Related]
10. RGD-containing peptides induce endothelium-dependent and independent vasorelaxations of rat aortic rings.
Lipke DW; Soltis EE; Fiscus RR; Yang L; Newman PS; Aziz SM
Regul Pept; 1996 May; 63(1):23-9. PubMed ID: 8795085
[TBL] [Abstract][Full Text] [Related]
11. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
[TBL] [Abstract][Full Text] [Related]
12. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
Foster MR; Hornby EJ; Brown S; Kitchin J; Hann M; Ward P
Thromb Res; 1993 Nov; 72(3):231-45. PubMed ID: 8303662
[TBL] [Abstract][Full Text] [Related]
13. Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit.
Amerini S; Filippi S; Parenti A; Ledda F; Ziche M
Br J Pharmacol; 1997 Dec; 122(8):1739-45. PubMed ID: 9422822
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide mediated endothelium-dependent relaxation induced by glibenclamide in rat isolated aorta.
Chan W; Yao X; Ko W; Huang Y
Cardiovasc Res; 2000 Apr; 46(1):180-7. PubMed ID: 10727666
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of platelet aggregation by fibrinogen-related peptides.
Adelman B; Gennings C; Strony J; Hanners E
Circ Res; 1990 Oct; 67(4):941-7. PubMed ID: 2208617
[TBL] [Abstract][Full Text] [Related]
16. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
[TBL] [Abstract][Full Text] [Related]
17. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
Cadroy Y; Houghten RA; Hanson SR
J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
[TBL] [Abstract][Full Text] [Related]
18. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure.
Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S
Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663
[TBL] [Abstract][Full Text] [Related]
19. Anti-metastatic and anti-invasive effects of polymeric Arg-Gly-Asp (RGD) peptide, poly(RGD), and its analogues.
Saiki I; Murata J; Matsuno K; Ogawa R; Nishi N; Tokura S; Azuma I
Jpn J Cancer Res; 1990; 81(6-7):660-7. PubMed ID: 2119367
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
